Definitive Contract HHSD200201691948C
Award Date
9/13/16
Potential Completion Date
3/19/18
Potential Value
$498K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $149,999.99 firm-fixed-price purchase order contract to the Trustees of Indiana University, doing business as Indiana University Iupui, for an ICD 9 study. The contract does not have a set-aside designation. Indiana University is a nonprofit, state-controlled institution of higher learning known for its research, education, and patient care services in areas such as genomics, neuroscience,...
This $299,984 firm-fixed-price purchase order was awarded by the Department of the Navy's Bureau of Medicine and Surgery (BUMED) to the Trustees of Indiana University, doing business as Indiana University, a major public research university. The contract is for the provision of laboratory services. Indiana University, a prolific recipient of federal research funding, has extensive expertise in biomedical sciences, information technology, and other disciplines that it leverages to support...
This is a $449,417 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Washington University for a study on "Fecal Microbiome Disruptions." The Washington University, a private research university, is serving as the prime contractor on this award. The contract does not appear to have any set-aside designation. The Washington University has extensive experience partnering with federal agencies like the Department of Defense, Department of...
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Virginia Commonwealth University (VCU) for the project "MICROBIOME DISRUPTION INDICES". The contract has a Firm Fixed Price structure and a ceiling value of $322,304.00. The period of performance ends on September 29, 2019. This award does not have a set-aside designation. VCU is a public research university that provides a wide range of services to the federal government, including...
This is a $283,965 firm fixed-price definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Northwestern University's Sponsored Research division. The contract, which does not have a set-aside designation, was awarded on September 30, 2018 and has a completion date of September 29, 2019. The contracted work involves research to address three key questions regarding the microbiomes of healthcare facility surfaces: 1) what...
This is a federal contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the Trustees of Indiana University (doing business as Indiana University), a public university system in Indiana. The contract, valued at $10,766,588.50, is for an extension of the period of performance and updated billing instructions. The contract type is a Definitive Contract with a Cost No Fee pricing type. There is no set-aside designation on this...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $387,955.00 firm fixed price contract to the Board of Regents of the University of Nebraska for in vitro and in vivo human microbiome models research. No set-aside was used for this award. The University of Nebraska is serving as the prime contractor, with Baylor College of Medicine as a subcontractor to perform work related to using complementary in vitro and in vivo models of the human microbiome...
This is a firm fixed price purchase order contract awarded by the National Library of Medicine, a component of the U.S. Department of Health and Human Services, to the Trustees of Indiana University (doing business as Indiana University) for $71,977.16. The contract is for professional services to acquire de-identified electronic medical records. The contract has no set-aside designation. Indiana University has served as both a prime contractor and subcontractor on numerous federal contracts and...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the Trustees of Indiana University, doing business as Indiana University, to manufacture and conduct biosafety testing of a gamma retroviral vector. The contract has a ceiling value of $120,710.88 and a period of performance ending on March 21, 2017. It does not have a set-aside designation. Indiana University is a major public...
This is a $459,721 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University, a private research university, to conduct research on "Microbiome Disruption Indices." The contract has no set-aside designation. As a subcontractor, the University of Maryland, Baltimore (UMB) is providing frozen patient samples and clinical data to support the research effort. This contract award is part of Yale University's broader portfolio of federal prime...